Company intelligence / Profile preview

Airon

Melbourne, Florida, USA

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Airon’s respiratory devices, including pneumatic ventilators and CPAP systems, are fully commercialized, FDA-cleared, and deployed globally in EMS, hospitals, and MRI environments, with established reliability and safety, especially highlighted during the Covid-19 pandemic when their technology was licensed at scale for emergency public health response[1][3][5].

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

GE Healthcare (technology licensee during Covid-19 pandemic)Ford (manufacturing partner for Covid-19 ventilator production)

Beyond the preview

Go deeper on Airon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Airon.

Explore the full profile